Suppr超能文献

前列腺素类药物和贝美前列素治疗眼的泪液生物标志物。

Tear biomarkers in latanoprost and bimatoprost treated eyes.

机构信息

Hyderabad Eye Research Foundation (HERF), L.V. Prasad Eye Institute, Bhubaneswar, India.

School of Biotechnology, KIIT University, Bhubaneswar, India.

出版信息

PLoS One. 2018 Aug 6;13(8):e0201740. doi: 10.1371/journal.pone.0201740. eCollection 2018.

Abstract

PURPOSE

Prostaglandin analogues (PGA's) are the mainstay and first line of treatment in current glaucoma practise. Though latanoprost and bimatoprost are the most commonly used PGA's with minimal side effects at lower concentrations like bimaotoprost 0.01%, direct comparison of their cytokine/MMP profile in tears has not been evaluated earlier. The study intends to ascribe PGA to the upregulation of MMPs, Cytokines and Chemokines mediating varied pathways to result in side effects of the drugs.

METHODS

Tear sample collection was done from outer canthus of 30 eyes of 30 patients (primary open angle glaucoma (n = 26 and n' = 20), normal tension glaucoma (n = 4 and n' = 10), in latanoprost (n) 0.005% and bimatoprost (n') 0.01% group respectively, with a mean age of 62±10.5 years) on >6 months of PGA use using Tear floTM Schirmer filter strip. Tear samples from 30 eyes of 30 cataract patients without drug treatment were used as the control. Gelatinolytic activity of MMP-9 and MMP-2 were examined by substrate gelatine zymography MMP-1 and TIMP-1 concentrations from tears samples with PGAs were evaluated by ELISA while cytokine concentration in the eluted tears was evaluated using a convenient bioplex kit assay (Milliplex MAP kit, HCYTMAG-60K-PX41, Millipore, Massachusetts, United States). The mean duration of use of PGA in both groups did not differ significantly (median 1.3 years in bimatoprost and 1.1 years in latanoprost eyes, p = 0.6).

RESULTS

The tear MMP-9 expression was higher in eyes receiving latanoprost while the MMP-2 expression was higher in eyes receiving bimatoprost with MMP1 protein levels being higher in the former. Latanoprost treated eyes had marginally elevated tear cytokines involved in tissue remodelling while bimatoprost eyes showed elevated cytokines regulating allergic pathways.

CONCLUSION

Differential cytokine and MMP expression indicates differential signalling pathways mediating different cellular effects (evident as clinical and side effects) with the two drugs which can be explored further.

摘要

目的

前列腺素类似物(PGAs)是当前青光眼治疗的主要药物和一线治疗药物。虽然拉坦前列素和贝美前列素是最常用的 PGA,低浓度下副作用最小,如贝美前列素 0.01%,但它们在泪液中的细胞因子/MMP 谱的直接比较尚未进行评估。本研究旨在将 PGA 归因于 MMPs、细胞因子和趋化因子的上调,这些因子介导不同的途径导致药物的副作用。

方法

从 30 名患者(原发性开角型青光眼(n = 26,n' = 20)、正常眼压性青光眼(n = 4,n' = 10))的外眼角收集泪液样本,使用 Tear floTM Schirmer 滤纸条分别在拉坦前列素(n)0.005%和贝美前列素(n')0.01%组中,平均年龄为 62±10.5 岁,使用前列腺素超过 6 个月。从 30 名未接受药物治疗的白内障患者的 30 只眼睛中采集泪液样本作为对照。使用底物明胶酶谱法检测 MMP-9 和 MMP-2 的明胶酶活性,通过 ELISA 评估来自使用 PGAs 的泪液样本中的 MMP-1 和 TIMP-1 浓度,同时使用方便的生物素试剂盒分析(Milliplex MAP 试剂盒,HCYTMAG-60K-PX41,Millipore,马萨诸塞州,美国)评估洗脱泪液中的细胞因子浓度。两组中 PGA 的平均使用时间无显著差异(中位数分别为贝美前列素组 1.3 年和拉坦前列素组 1.1 年,p = 0.6)。

结果

接受拉坦前列素治疗的眼睛中泪液 MMP-9 表达较高,而接受贝美前列素治疗的眼睛中 MMP-2 表达较高,前者的 MMP1 蛋白水平较高。拉坦前列素治疗的眼睛中参与组织重塑的泪液细胞因子水平升高,而贝美前列素治疗的眼睛中调节过敏途径的细胞因子水平升高。

结论

细胞因子和 MMP 表达的差异表明,两种药物介导不同的细胞效应(表现在临床和副作用上)的信号通路不同,这可以进一步探讨。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e70c/6078293/e02890ddd3a3/pone.0201740.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验